ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Flammazine:Alliance Pharmaceuticals GmbH, Düsseldorf, Zweigniederlassung Uster
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
D06BA01 - Silver SulfadiazineATC-DDD Version 2016. Source: WHO
D - Dermatologicals

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.

D06 - Antibiotics and Chemotherapeutics for Dermatological Use

This group comprises products for topical use in skin infections etc.
Antimicrobial chemotherapeutics are classified here, while antineoplastic chemotherapeutics are classified in L01.

D06B - Chemotherapeutics for Topical Use

This group includes antimicrobial chemotherapeutics for dermatological use, except:
Combinations with antibiotics - D06C
Combinations with corticosteroids - D07C
Antineoplastic chemotherapeutics are classified in L01 - Antineoplastic agents.

D06BA - Sulfonamides
 
D06BA01 - Silver Sulfadiazine
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home